News

AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer

News

SEATTLE – November 1, 2021 – AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been appointed as the company’s Chief Business Officer (CBO). In this position, he is responsible for strategic leadership over all aspects of the company’s global business development and sales and marketing teams.  
Follow Us
Join us on LinkedIn Follow us on Twitter